Evidence map›Paper›PMID 37553092›Full record

ReviewJournal of the American Chemical Society2023

Charting the Evolution of Chemoenzymatic Strategies in the Syntheses of Complex Natural Products.

Carter N Stout, Nour M Wasfy, Fang Chen, Hans Renata

Abstract readReview
In one paragraph

Review in Journal of the American Chemical Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. RNA chemistry and therapeutics.Nature reviews. Drug discovery · 2025
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Total Synthesis FacilitatesJournal of the American Chemical Society · 2024
    Article
  13. Review
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Carter N StoutSkaggs Doctoral Program in the Chemical and Biological Sciences, Scripps Research, La Jolla, California 92037, United States.
Nour M WasfyDepartment of Chemistry, BioScience Research Collaborative, Rice University, Houston, Texas 77005, United States.
Fang ChenDepartment of Chemistry, BioScience Research Collaborative, Rice University, Houston, Texas 77005, United States.
Hans RenataDepartment of Chemistry, BioScience Research Collaborative, Rice University, Houston, Texas 77005, United States.ORCID 0000-0003-2468-2328

Funding

Biocatalytic C-H Functionalization Logic in the Chemoenzymatic Synthesis of Therapeutic Natural ProductsR35GM128895 · NIGMS · UNIVERSITY OF FLORIDA · PI Hans Renata · 2018 to 2026
$3.7M
NIGMS NIH HHS R35 GM128895
6 · The paper itself

Abstract

Bolstered by recent advances in bioinformatics, genetics, and enzyme engineering, the field of chemoenzymatic synthesis has enjoyed a rapid increase in popularity and utility. This Perspective explores the integration of enzymes into multistep chemical syntheses, highlighting the unique potential of biocatalytic transformations to streamline the synthesis of complex natural products. In particular, we identify four primary conceptual approaches to chemoenzymatic synthesis and illustrate each with a number of landmark case studies. Future opportunities and challenges are also discussed.

Indexed as

Biological ProductsBiocatalysisBiological Products

Identifiers

PMID37553092
PMCPMC11107883

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.